Covered recipient · General Payments record
DORIS VOY KAN QUON
Allopathic & Osteopathic Physicians Internal Medicine Hematology
A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.
Saved only in this browser. No account or alerts.
General Payments · PY2019 · Entire year
$226,862.23
214 records · 0 disputed
“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”
— Centers for Medicare & Medicaid Services, Open Payments
A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.
These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.
A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.
How these totals are calculated
- This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Methodology & Data — sourcing, labeling, and limitations.
Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗
By nature of payment
PY2019 · entire year · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $133,768.83 | 35 |
| Consulting Fee | $47,886.00 | 10 |
| Travel and Lodging | $37,008.24 | 90 |
| Food and Beverage | $5,692.16 | 77 |
| Honoraria | $2,500.00 | 1 |
| Education | $7.00 | 1 |
By paying entity
PY2019 · entire year · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Shire North American Group Inc | $83,768.23 | 76 |
| Genentech USA, Inc. | $51,497.59 | 40 |
| Novo Nordisk Inc | $34,709.54 | 16 |
| BIOVERATIV THERAPEUTICS INC. | $29,080.04 | 24 |
| BioMarin Pharmaceutical Inc. | $16,175.83 | 16 |
| Bayer HealthCare Pharmaceuticals Inc. | $7,044.16 | 14 |
| Octapharma USA, Inc. | $3,835.13 | 8 |
| Spark Therapeutics, Inc. | $298.72 | 4 |
| E.R. Squibb & Sons, L.L.C. | $111.15 | 1 |
| Daiichi Sankyo Inc. | $49.15 | 2 |
| Array BioPharma Inc. | $48.47 | 2 |
| SANOFI-AVENTIS U.S. LLC | $44.99 | 1 |
| Kyowa Kirin, Inc. | $44.44 | 2 |
| Puma Biotechnology, Inc. | $24.12 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $22.55 | 1 |
| EISAI INC. | $20.72 | 1 |
| PFIZER INC. | $20.63 | 1 |
| Janssen Biotech, Inc. | $20.19 | 1 |
| Teva Pharmaceuticals USA, Inc. | $19.30 | 1 |
| Clovis Oncology, Inc. | $15.72 | 1 |
| Partner Therapeutics, Inc. | $11.56 | 1 |
Page 4 of 5; records 151–200 of 214 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.
IndustryPayments · General Payments
DORIS VOY KAN QUON
NPI 1578589271 · CMS profile ID 297740
Allopathic & Osteopathic Physicians / Internal Medicine / Hematology
LOS ANGELES, CA
A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.
A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.
General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types
Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00
Page 4 of 5; records 151–200 of 214 matching records. This page contains 50 records (maximum 50), not the full filtered export.
Filtered page: https://industrypayments.org/provider/npi-1578589271?year=2019&recipient=provider&page=4#records-h
CMS source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e
Cite these filtered records
The citation includes this program year, filters, data edition, and page of results.
- Plain
- DORIS VOY KAN QUON, NPI 1578589271, CMS profile ID 297740. General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 4 of 5; records 151–200 of 214 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1578589271?year=2019&recipient=provider&page=4#records-h. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e.
- APA 7
- IndustryPayments. (2026). DORIS VOY KAN QUON, NPI 1578589271, CMS profile ID 297740. General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 4 of 5; records 151–200 of 214 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1578589271?year=2019&recipient=provider&page=4#records-h. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e.
- Bluebook
- DORIS VOY KAN QUON, NPI 1578589271, CMS profile ID 297740, IndustryPayments, General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 4 of 5; records 151–200 of 214 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e. https://industrypayments.org/provider/npi-1578589271?year=2019&recipient=provider&page=4#records-h.
Centers for Medicare & Medicaid Services, Open Payments
Citation formats are provided for reference; check the requirements of your publication.
Payment records · PY2019
Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them
General Payments · PY2019 · Physicians and non-physician practitioners · CMS publication 2026-06-30
214 matching records · $226,862.23 reported total · 0 disputed
Nature of payment: All payment types
Records imported here (UTC).
CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.
Showing records 151–200 of 214.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Publication flags | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|---|
| Bayer HealthCare Pharmaceuticals Inc. | $8.33 | 04/03/2019 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 628487513 | CMS |
| Genentech USA, Inc. | $38.50 | 03/29/2019 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 681152035 | CMS |
| Genentech USA, Inc. | $92.79 | 03/29/2019 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 681297615 | CMS |
| Bayer HealthCare Pharmaceuticals Inc. | $30.79 | 03/23/2019 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 628418981 | CMS |
| Bayer HealthCare Pharmaceuticals Inc. | $61.31 | 03/23/2019 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 628421433 | CMS |
| Bayer HealthCare Pharmaceuticals Inc. | $65.48 | 03/23/2019 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 628431201 | CMS |
| Bayer HealthCare Pharmaceuticals Inc. | $30.00 | 03/23/2019 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 628439165 | CMS |
| Bayer HealthCare Pharmaceuticals Inc. | $6,000.00 | 03/23/2019 | Consulting Fee | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 628443459 | CMS |
| Bayer HealthCare Pharmaceuticals Inc. | $63.98 | 03/23/2019 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 628463405 | CMS |
| Bayer HealthCare Pharmaceuticals Inc. | $108.61 | 03/23/2019 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 628467381 | CMS |
| Bayer HealthCare Pharmaceuticals Inc. | $49.99 | 03/23/2019 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 628474967 | CMS |
| Bayer HealthCare Pharmaceuticals Inc. | $124.99 | 03/23/2019 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 628480119 | CMS |
| Bayer HealthCare Pharmaceuticals Inc. | $220.42 | 03/23/2019 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 628482875 | CMS |
| BioMarin Pharmaceutical Inc. | $140.61 | 03/22/2019 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 673858437 | CMS |
| BIOVERATIV THERAPEUTICS INC. | $1,206.00 | 03/21/2019 | Consulting Fee | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 693966441 | CMS |
| BioMarin Pharmaceutical Inc. | $25.39 | 03/21/2019 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 673856213 | CMS |
| BioMarin Pharmaceutical Inc. | $243.87 | 03/21/2019 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 673856293 | CMS |
| BioMarin Pharmaceutical Inc. | $630.45 | 03/21/2019 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 673856295 | CMS |
| BioMarin Pharmaceutical Inc. | $383.61 | 03/21/2019 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 673856337 | CMS |
| BioMarin Pharmaceutical Inc. | $335.13 | 03/21/2019 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 673858455 | CMS |
| BioMarin Pharmaceutical Inc. | $70.91 | 03/21/2019 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 673858457 | CMS |
| BioMarin Pharmaceutical Inc. | $76.13 | 03/21/2019 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 673858459 | CMS |
| BioMarin Pharmaceutical Inc. | $345.40 | 03/21/2019 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 673858955 | CMS |
| Bayer HealthCare Pharmaceuticals Inc. | $150.51 | 03/12/2019 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 628438543 | CMS |
| Shire North American Group Inc | $21.65 | 03/06/2019 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 637899799 | CMS |
| Shire North American Group Inc | $33.84 | 03/06/2019 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 637899801 | CMS |
| Shire North American Group Inc | $46.64 | 03/06/2019 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 637899803 | CMS |
| Shire North American Group Inc | $9.18 | 03/06/2019 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 637899805 | CMS |
| Shire North American Group Inc | $3,700.00 | 03/04/2019 | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 637899797 | CMS |
| Genentech USA, Inc. | $124.09 | 02/28/2019 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 681173675 | CMS |
| Genentech USA, Inc. | $5,280.00 | 02/28/2019 | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 681276111 | CMS |
| Genentech USA, Inc. | $636.80 | 02/28/2019 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 681281167 | CMS |
| BIOVERATIV THERAPEUTICS INC. | $108.58 | 02/26/2019 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 694260195 | CMS |
| BIOVERATIV THERAPEUTICS INC. | $6,110.00 | 02/26/2019 | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 694266293 | CMS |
| BIOVERATIV THERAPEUTICS INC. | $302.20 | 02/26/2019 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 694266295 | CMS |
| BIOVERATIV THERAPEUTICS INC. | $376.67 | 02/26/2019 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 694266297 | CMS |
| BIOVERATIV THERAPEUTICS INC. | $139.49 | 02/26/2019 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 694266299 | CMS |
| Array BioPharma Inc. | $23.88 | 02/25/2019 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 700973283 | CMS |
| Puma Biotechnology, Inc. | $24.12 | 02/23/2019 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 706024681 | CMS |
| Shire North American Group Inc | $192.44 | 02/21/2019 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 637899793 | CMS |
| Shire North American Group Inc | $122.45 | 02/21/2019 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 637899795 | CMS |
| Genentech USA, Inc. | $120.66 | 02/20/2019 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 681209627 | CMS |
| Genentech USA, Inc. | $560.21 | 02/06/2019 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 681207525 | CMS |
| Genentech USA, Inc. | $119.48 | 02/06/2019 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 681299077 | CMS |
| Genentech USA, Inc. | $150.29 | 02/06/2019 | Travel and Lodging | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 681310197 | CMS |
| Genentech USA, Inc. | $5,280.00 | 02/06/2019 | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 681315645 | CMS |
| BIOVERATIV THERAPEUTICS INC. | $1,880.00 | 02/05/2019 | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 694265729 | CMS |
| Genentech USA, Inc. | $71.22 | 02/02/2019 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 681257567 | CMS |
| Janssen Biotech, Inc. | $20.19 | 02/01/2019 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 658657435 | CMS |
| Novo Nordisk Inc | $6.12 | 01/29/2019 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 705943023 | CMS |
By program year
All program years on this page · sorted by year
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
- Source files
- Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.
Research Payments
One row per program year and role, newest year first · amounts for the two roles are never added together
| Program year | Role | Amount | Records |
|---|---|---|---|
| PY2025 | Recipient | $11,776.00 | 1 |
| PY2025 | Principal investigator | $68,008.58 | 17 |
| PY2024 | Principal investigator | $114,372.92 | 34 |
| PY2023 | Recipient | $2,750.00 | 7 |
| PY2023 | Principal investigator | $37,805.79 | 21 |
| PY2022 | Recipient | $8,190.00 | 4 |
| PY2022 | Principal investigator | $49,912.90 | 6 |
| PY2021 | Recipient | $250.00 | 1 |
| PY2021 | Principal investigator | $63,451.55 | 14 |
| PY2020 | Recipient | $4,503.36 | 6 |
| PY2020 | Principal investigator | $35,874.90 | 17 |
| PY2019 | Recipient | $2,870.91 | 7 |
| PY2019 | Principal investigator | $189,684.85 | 30 |
Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.
“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”
— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224
Research Payments records · PY2025
Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them
18 records in PY2025
| Role | Paying entity | Amount | Date | Recipient | Study | Dispute status | Published | Record ID |
|---|---|---|---|---|---|---|---|---|
| Principal investigator 1 | BioMarin Pharmaceutical Inc. | $777.40 | 11/17/2025 | Non-covered Recipient Entity Orthopaedic Hospital | BMN 270-401 | No dispute reported | 06/30/2026 | 1248579955 |
| Principal investigator 1 | Genentech, Inc. | $16,430.00 | 10/24/2025 | Non-covered Recipient Entity ORTHOPAEDIC INSTITUTE FOR CHILDREN | A STUDY TO EVALUATE JOINT HEALTH PHYSICAL ACTIVITY AND HEALTH RELATED QUALITY OF LIFE IN PATIENT | No dispute reported | 06/30/2026 | 1211635998 |
| Principal investigator 1 | HEMA Biologics, LLC | $1,500.00 | 10/17/2025 | Non-covered Recipient Entity ORTHOPAEDIC INSTITUTE FOR CHILDRENORTHOPAEDIC HEMOPHILIA TREATMENT CENTER | Retrospective Experience Assessing the Real-World Utilization and Effectiveness of SEVENFACT | No dispute reported | 06/30/2026 | 1211421449 |
| Principal investigator 1 | BioMarin Pharmaceutical Inc. | $778.70 | 09/18/2025 | Non-covered Recipient Entity Orthopaedic Hospital | BMN 270-401 | No dispute reported | 06/30/2026 | 1248579953 |
| Principal investigator 1 | Genentech, Inc. | $9,711.00 | 08/28/2025 | Non-covered Recipient Entity ORTHOPAEDIC INSTITUTE FOR CHILDREN | A STUDY TO EVALUATE JOINT HEALTH PHYSICAL ACTIVITY AND HEALTH RELATED QUALITY OF LIFE IN PATIENT | No dispute reported | 06/30/2026 | 1211635994 |
| Principal investigator 1 | PFIZER INC. | $6,143.66 | 08/22/2025 | Non-covered Recipient Entity Orthopaedic Hospital dba Orthopaedic Hemophilia Treatment Center | A PHASE 1B OPENLABEL NONRANDOMIZED STUDY TO ASSESS THE SAFETY PHARMACOKINETICS AND PHARMACODYNAMICS OF MARSTACIMAB TREATMENT FOLLOWING THE DISCONTINUATION OF EMICIZUMAB THERAPY IN ADOLESCENT AND ADULT PARTICIPANTS WITH SEVERE HEMOPHILIA A WITHOUT INHIBITORS | No dispute reported | 06/30/2026 | 1228766565 |
| Principal investigator 1 | BioMarin Pharmaceutical Inc. | $1,037.40 | 08/14/2025 | Non-covered Recipient Entity Orthopaedic Hospital | BMN 270-401 | No dispute reported | 06/30/2026 | 1248579951 |
| Principal investigator 1 | PFIZER INC. | $6,143.66 | 08/02/2025 | Non-covered Recipient Entity Orthopaedic Hospital dba Orthopaedic Hemophilia Treatment Center | A PHASE 1B OPENLABEL NONRANDOMIZED STUDY TO ASSESS THE SAFETY PHARMACOKINETICS AND PHARMACODYNAMICS OF MARSTACIMAB TREATMENT FOLLOWING THE DISCONTINUATION OF EMICIZUMAB THERAPY IN ADOLESCENT AND ADULT PARTICIPANTS WITH SEVERE HEMOPHILIA A WITHOUT INHIBITORS | No dispute reported | 06/30/2026 | 1228767551 |
| Principal investigator 1 | PFIZER INC. | $10,128.00 | 06/26/2025 | Non-covered Recipient Entity Orthopaedic Hospital dba Orthopaedic Hemophilia Treatment Center | A PHASE 1B OPENLABEL NONRANDOMIZED STUDY TO ASSESS THE SAFETY PHARMACOKINETICS AND PHARMACODYNAMICS OF MARSTACIMAB TREATMENT FOLLOWING THE DISCONTINUATION OF EMICIZUMAB THERAPY IN ADOLESCENT AND ADULT PARTICIPANTS WITH SEVERE HEMOPHILIA A WITHOUT INHIBITORS | No dispute reported | 06/30/2026 | 1228776875 |
| Principal investigator 1 | BioMarin Pharmaceutical Inc. | $1,556.10 | 05/30/2025 | Non-covered Recipient Entity Orthopaedic Hospital | BMN 270-401 | No dispute reported | 06/30/2026 | 1248579949 |
| Principal investigator 1 | CSL Behring | $18.00 | 05/27/2025 | Non-covered Recipient Entity Orthopaedic Institute for Children | An Extension Study Assessing the Long-term Safety and Efficacy of Etranacogene Dezaparvovec (CSL222) Previously Administered to Adult Male Subjects With Hemophilia B | No dispute reported | 06/30/2026 | 1252666131 |
| Principal investigator 1 | Bayer Healthcare Pharmaceuticals Inc. | $650.00 | 05/19/2025 | Non-covered Recipient Entity The Luskin Oic Medical Pavilion And Ambulatory Surgery Center | BAY 949027, HEM-POWR Observational Study Evaluating Effectiveness and Safety of Real-World Treatment with Damoctocog alfa pegol in Previously Treated Patients with Hemophilia A | No dispute reported | 06/30/2026 | 1225408846 |
| Principal investigator 1 | BioMarin Pharmaceutical Inc. | $2,298.40 | 04/16/2025 | Non-covered Recipient Entity Orthopaedic Hospital | BMN 270-401 | No dispute reported | 06/30/2026 | 1248579947 |
| Recipient | F. Hoffmann-La Roche AG | $11,776.00 | 03/31/2025 | Covered Recipient Physician | A literature review of major surgery experience with emicizumab in people with hemophilia A without factor VIII inhibitors | No dispute reported | 06/30/2026 | 1211535512 |
| Principal investigator 1 | BioMarin Pharmaceutical Inc. | $4,596.80 | 03/14/2025 | Non-covered Recipient Entity Orthopaedic Hospital | BMN 270-401 | No dispute reported | 06/30/2026 | 1248579945 |
| Principal investigator 1 | HEMA Biologics, LLC | $3,000.00 | 02/26/2025 | Non-covered Recipient Entity ORTHOPAEDIC HOSPITAL | ATHN 16 | No dispute reported | 06/30/2026 | 1211421429 |
| Principal investigator 1 | SANOFI US SERVICES INC. | $1,683.36 | 02/18/2025 | Non-covered Recipient Entity Orthopaedic Institute For Children | OBS effectiveness of Efanesoctocog alfa prophylaxis on joint health in previously treated HEMOA patients | No dispute reported | 06/30/2026 | 1226108103 |
| Principal investigator 1 | BioMarin Pharmaceutical Inc. | $1,556.10 | 02/14/2025 | Non-covered Recipient Entity Orthopaedic Hospital | BMN 270-401 | No dispute reported | 06/30/2026 | 1248579943 |